Knight Therapeutics Inc. (OTCMKTS:KHTRF – Get Free Report) traded up 0.6% during trading on Wednesday . The stock traded as high as $4.3765 and last traded at $4.3765. 2,000 shares changed hands during mid-day trading, a decline of 34% from the average session volume of 3,048 shares. The stock had previously closed at $4.35.
Knight Therapeutics Trading Up 0.6%
The firm’s 50 day simple moving average is $4.30 and its 200-day simple moving average is $4.41.
About Knight Therapeutics
Knight Therapeutics Inc (OTCMKTS:KHTRF) is a specialty pharmaceutical company headquartered in Montreal, Canada, focused on acquiring, in-licensing and commercializing innovative branded products for the Canadian and Latin American markets. The company secures exclusive marketing and distribution rights to medicines across multiple therapeutic areas, including ophthalmology, pain management, hematology and women’s health. Its portfolio features both prescription pharmaceuticals and specialty products that address unmet patient needs through targeted treatments.
Operating primarily in Canada, Mexico and select Latin American countries, Knight has established strategic alliances with global pharmaceutical firms to introduce novel therapies at various stages of development.
See Also
- Five stocks we like better than Knight Therapeutics
- Do not delete, read immediately
- The Crash Has Already Started (Most Just Don’t See It Yet)
- ALERT: Drop these 5 stocks before January 2026!
- [No Brainer Gold Play]: “Show me a better investment.”
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Receive News & Ratings for Knight Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Knight Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
